Nambiar, Dhanya K <br/><br/>
Galectin-1-driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance.  [electronic resource] 

 -  The Journal of clinical investigation  12 2019 
 - 5553-5567 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1558-8238 
<br/><br/><label>Standard No.: </label>10.1172/JCI129025  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Animals<br/>B7-H1 Antigen--antagonists & inhibitors<br/>Endothelium--physiology<br/>Female<br/>Galectin 1--antagonists & inhibitors<br/>Galectins--physiology<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Immune Tolerance<br/>Immunotherapy<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Middle Aged<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>STAT1 Transcription Factor--physiology<br/>T-Lymphocytes--immunology